Contaminated syrups from the Indian pharmaceutical company Maiden. /
The WHO warns that they contain an “unacceptable amount of diethylene glycol and ethylene glycol” and that they could have been distributed “informally” to other countries
At least 69 minors have died in Gambia due to the damage caused to their kidneys by four possibly contaminated cough syrups manufactured by the Indian pharmaceutical company Maiden Pharmaceuticals, according to a new balance sheet by the Gambian Minister of Health, Ahmadu Lamin Samaté, in a press conference. press collected by Bloomberg.
Gambian President Adama Barrow has ordered the suspension of the drugmaker’s license and directed his foreign minister to raise the matter with the Indian ambassador in Banjul, according to a presidential statement released on Saturday night.
“Laboratory analysis of samples of all four products confirms that they contain an unacceptable amount of diethylene glycol and ethylene glycol. To date, these four products have been identified in The Gambia, but they could have been distributed informally to other countries or regions,” the WHO pointed out in an official alert.
“unsafe” products
The four syrups are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup, and Magrip N Cold Syrup. All batches of these products “should be considered unsafe” until they have been analyzed by the respective national authorities.
The Central Organization for Quality Control of Indian Medicines has opened an investigation into these syrups after receiving the first reports on September 29.
Several medicines from the company Maiden Pharmaceuticals have been rejected by the Indian authorities and Vietnam directly vetoed all of its products in 2011. The pharmaceutical company assures on its website that it sells products to other countries in Asia, Africa and Latin America.
#children #die #Gambia #Indianmade #cough #syrups
